Soleno Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SLNO and buy or sell other stocks, ETFs, and their options commission-free!

About SLNO

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. The firm focuses on the treatment of metabolic and neurobehavioral disorder. 

CEO
Anish Bhatnagar
CEOAnish Bhatnagar
Employees
31
Employees31
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
1999
Founded1999
Employees
31
Employees31

SLNO Key Statistics

Market cap
6.44B
Market cap6.44B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
805.78K
Average volume805.78K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.9699
52 Week high$0.9699
52 Week low
$0.1302
52 Week low$0.1302

Stock Snapshot

Soleno Therapeutics(SLNO) stock is priced at $53.01, giving the company a market capitalization of 6.44B.

During the trading day, Soleno Therapeutics(SLNO) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 805.78K.

The stock's 52-week range extends from a low of $0.13 to a high of $0.97.

The stock's 52-week range extends from a low of $0.13 to a high of $0.97.

People also own

Based on the portfolios of people who own SLNO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.